Trade JSPR anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Jasper Therapeutics, Inc. (JSPR) is trading at US$0.68, down 3.18% today as of Aug 28, 12:58 EDT. The company has a market capitalisation of US$23.82M. Over the past 52 weeks, JSPR has traded between US$0.32 and US$2.87. On Syfe you can trade JSPR with $0 commission and add it to your watchlist.
| Previous close | US$0.70 |
|---|---|
| Market cap | US$23.82M |
| 52-week range | US$0.32 – US$2.87 |
| Volume | 252.15K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
Year: 2021
Jasper Therapeutics Completes Merger With Kira Pharmaceuticals, Shares Fall
Jul 16, 9:42 PM · MT Newswires
Sector Update: Healthcare Stocks Fall Late Afternoon
Jun 1, 7:53 PM · MT Newswires
Sector Update: Healthcare Stocks Fall in Afternoon Trading
Jun 1, 5:49 PM · MT Newswires
Sector Update: Healthcare
Jun 1, 5:13 PM · MT Newswires
Jasper Therapeutics, Inc. (JSPR) stock is trading at US$0.68, -3.18% from the previous close of US$0.70.
The market cap for Jasper Therapeutics, Inc. (JSPR) stock is approximately US$23.82M.
The 52-week high for Jasper Therapeutics, Inc. (JSPR) stock is US$2.87.
The 52-week low for Jasper Therapeutics, Inc. (JSPR) stock is US$0.32.
Jasper Therapeutics, Inc. (JSPR) does not currently pay a dividend.
Stay on top of JSPR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
